There is an Extended-Release ADHD Treatment Option Available
(WorldNews Health)

(BPT) - An estimated 4.4 percent of adults have Attention Deficit Hyperactivity Disorder (ADHD) in the U.S. - which means that when applied to the full U.S. adult population aged 18 and over, approximately 10.5 million adults are estimated to have ADHD. Medication is not appropriate for all individuals diagnosed with ADHD. ADHD is a neurodevelopmental disorder that manifests as a persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. Many of these adults struggle with symptom management as they go through their day. On June 20, 2017, the U.S. Food and Drug Administration (FDA) approved MYDAYIS® (mixed salts of a single-entity...